-
Abstract Number: 0001
A Single-Cell and Spatial Transcriptomic Atlas of the Inflamed Aorta: Decoding the Pathogenesis of Clinically Isolated Aortitis
-
Abstract Number: 0002
Age-Related Antigen Discovery in Giant Cell Arteritis
-
Abstract Number: 0003
Association of Increasing Genetically-Mediated Complement Activity with ANCA-Associated Vasculitis
-
Abstract Number: 0004
Baseline and early longitudinal serum biomarkers in Polymyalgia Rheumatica: kinetics and associations with clinical course
-
Abstract Number: 0005
Is the HLA-B*52 allele associated with an increased risk of developing Takayasu arteritis in Brazil? A Monocenter Cross-Sectional Study.
-
Abstract Number: 0006
Polygenic Risk for Nasal Polyps in ANCA-Associated Vasculitis
-
Abstract Number: 0008
Transcriptome analysis of temporal artery and aortic lesions highlights vessel-specific chemotaxis and cell adhesion in GCA
-
Abstract Number: 0009
An Ex-Vivo Functional Immune Assay Predicts TNF Inhibitor Response Across T Cell-Mediated Autoimmune Diseases
-
Abstract Number: 0010
Induction of B Cell Aplasia with cGP130 Armored-CAR T Cells Without Lymphodepletion
-
Abstract Number: 0011
PD-1+CD8+ T cells are hyperactivated and associated with refractory systemic lupus erythematosus
-
Abstract Number: 0012
Peripheral T Cell Immunophenotyping Identifies Terminally Differentiated Cytotoxic CD8 T Cell Expansion, Effector Memory T Cell Depletion, and anti-Ro-Associated CD38⁺ CD4 T Cell Activation in Sjögren’s Disease
-
Abstract Number: 0013
Profiling U170-Specific Self-Reactive CD4+ T cells in MCTD and SLE
-
Abstract Number: 0014
PsoriAxis Reveals Continuous Molecular Healing and Residual Disease States in Psoriasis
-
Abstract Number: 0015
Ro+ Sjögren’s disease patients display selective enrichment of TCR V/J genes in the salivary gland with a distinguishing clonal profile
-
Abstract Number: 0016
Small-Molecule Inhibitors of TNF Reduce Pro-inflammatory Disease Activity while Retaining TNFR2 Signaling, Which Preserves the Suppressive Capacity of Regulatory T Cells and Promotes Immune Tolerance
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.